Cancer · August 14, 2026
FDA Approves Iberdomide Combo for Relapsed Multiple Myeloma Patients
FDA approves a novel iberdomide treatment regimen for relapsed/refractory multiple myeloma patients....
Treatment · March 27, 2026
European Regulators Recommend Five New Therapies Including Easier to Use Myeloma Treatment
European regulatory committee recommends approval of Sanofi's Sarclisa and four additional new medications....
Cancer · March 23, 2026
New FDA Guidance Accelerates Myeloma Drug Approvals and Patient Access
Researchers achieve significant progress in developing new myeloma treatments....